COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience

AM Shields, SO Burns, S Savic, AG Richter… - Journal of Allergy and …, 2021 - Elsevier
Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …
被引用次数：241 相关文章

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

AM Shields, SO Burns, S Savic… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …

COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience

AM Shields, SO Burns, S Savic… - Journal of Allergy and …, 2021 - eprints.whiterose.ac.uk
Background: As of November 2020, SARS-CoV-2 has resulted in 55 million infections
worldwide and over 1.3 million deaths from COVID-19. Outcomes following SARS-CoV-2 …
[HTML] nih.gov

[HTML][HTML] COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

AM Shields, SO Burns, S Savic, AG Richter… - The Journal of Allergy …, 2021 - ncbi.nlm.nih.gov
Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

AM Shields, SO Burns, S Savic, AG Richter… - Journal of Allergy and …, 2021 - eprints.ncl.ac.uk
Abstract© 2020 American Academy of Allergy, Asthma & ImmunologyBackground: As of
November 2020, severe acute respiratory syndrome coronavirus 2 has resulted in 55 million …

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.

AM Shields, SO Burns, S Savic… - The Journal of Allergy …, 2020 - europepmc.org
Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …

COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience.

AM Shields, SO Burns, S Savic, AG Richter… - 2021 - cabidigitallibrary.org
Abstract Background: As of November 2020, severe acute respiratory syndrome coronavirus
2 has resulted in 55 million infections worldwide and more than 1.3 million deaths from …

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

AM Shields, SO Burns, S Savic… - Journal of Allergy …, 2021 - discovery.ucl.ac.uk
BACKGROUND: As of November 2020, severe acute respiratory syndrome coronavirus 2
has resulted in 55 million infections worldwide and more than 1.3 million deaths from …
[PDF] academia.edu

[PDF][PDF] COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

AM Shields, SO Burns, S Savic - Allergy, 2021 - academia.edu
Background: As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

AM Shields, SO Burns, S Savic, AG Richter… - Journal of Allergy and …, 2021 - jacionline.org
Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …